Farallon Capital Management LLC Ventyx Biosciences, Inc. Transaction History
Farallon Capital Management LLC
- $21.4 Billion
- Q1 2024
A detailed history of Farallon Capital Management LLC transactions in Ventyx Biosciences, Inc. stock. As of the latest transaction made, Farallon Capital Management LLC holds 3,170,000 shares of VTYX stock, worth $15.2 Million. This represents 0.08% of its overall portfolio holdings.
Number of Shares
3,170,000
Previous 3,170,000
-0.0%
Holding current value
$15.2 Million
Previous $17.4 Million
-0.0%
% of portfolio
0.08%
Previous 0.08%
Shares
4 transactions
Others Institutions Holding VTYX
# of Institutions
134Shares Held
59.2MCall Options Held
180KPut Options Held
179K-
Ken Griffin Citadel Advisors LLC | Chicago, Il5.89MShares$28.2 Million0.01% of portfolio
-
Black Rock Inc. New York, NY3.75MShares$17.9 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.71MShares$17.7 Million0.0% of portfolio
-
Deerfield Management Company, L.P. (Series C) New York, NY3.54MShares$16.9 Million0.4% of portfolio
-
Tang Capital Management LLC San Diego, CA3.1MShares$14.8 Million2.08% of portfolio
About Ventyx Biosciences, Inc.
- Ticker VTYX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 56,527,200
- Market Cap $270M
- Description
- Ventyx Biosciences, Inc., a clinical-stage biopharmaceutical company, develops small molecule product candidates for inflammatory diseases and autoimmune disorders. The company's lead product candidate is VTX958, a tyrosine kinase type 2 inhibitor that is in phase I clinical trials for the treatment of immune-mediated diseases, such as psoriasis...